Skip to main content
SpringerLink
Log in

Harmonisation in Pharmacovigilance

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • US Food and Drug Administration. 21 GFR 314.80 Federal Register 50 (30): 7500, 1985

    Google Scholar 

  • Council for International Organizations of Medical Sciences. International reporting of adverse drug reactions, CIOMS, Geneva, 1990

    Google Scholar 

  • Delamothe T. Reporting adverse drug reactions. British Medical Journal 304: 465, 1992

    Google Scholar 

  • European Commission. CPMP Working Party. Notes for guidance 111/3976/88-EN. European Commission, Brussels, 1988

    Google Scholar 

  • European Commission. Notice to applicants III73567/92, pp. 125–126, Brussels, 1993

    Google Scholar 

  • International Committee on Harmonization. Clinical safety data management: definitions and standards for expedited reporting ICH-2 EWG E2, in press, 1994

    Google Scholar 

  • Karch FE, Lasagna L. Adverse drug reactions. Journal of the American Medical Association 234: 1236–1239, 1975

    Article  PubMed  CAS  Google Scholar 

  • Leon DA. Failed or misleading adjustment for confounding. Lancet 342: 479–481, 1993

    Article  PubMed  CAS  Google Scholar 

  • Stephens MDB. Detection of new adverse drug reactions, 3rd ed., Macmillan Publishers Ltd, Basingstoke, 1992

    Google Scholar 

  • Waller PC, Wood SM, Langman MJS, Breckenridge AM, Rawlins MD. Review of company post-marketing studies. British Medical Journal 304: 1470–1472, 1992

    Article  PubMed  CAS  Google Scholar 

  • World Health Organization. Technical Report Series No 498, World Health Organization, Geneva, 1972

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. WHO Collaborating Centre for International Drug Monitoring, Box 26, S-751 03, Uppsala, Sweden

    I. Ralph Edwards (Medical Director) & Cecilia Biriell

Authors
  1. I. Ralph Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cecilia Biriell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edwards, I.R., Biriell, C. Harmonisation in Pharmacovigilance. Drug-Safety 10, 93–102 (1994). https://doi.org/10.2165/00002018-199410020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199410020-00001

Keywords

Search

Navigation